Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F receptor

Thomas J. Weber, Lye M. Markillie, William B. Chrisler, George A. Vielhauer, John W Regan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Prostaglandin F (PGF) modulates clonal selection processes in the mouse skin model of carcinogenesis. In this study we investigated whether JB6 mouse epidermal cells expressed a functional PGF receptor (FP) coupled with a cell-transformation response. Treatment of JB6 cells with an FP agonist (fluprostenol) potently (pM-nM) increased anchorage-dependent and anchorage-independent growth. Inositol phospholipid accumulation and extracellular signal-regulated kinase (Erk) activity were increased in cells treated with FP agonists, consistent with established FP- related signal transduction. FP mRNA was detected by reverse transcription-polymerase chain reaction, and the average specific [3H]PGF binding was 8.25 ± 0.95 fmol/mg protein. Erk activity and colony size were increased by cotreatment of JB6 cells with epidermal growth factor (EGF) and fluprostenol to a greater extent than with either treatment alone, whereas the cotreatment effect on colony number appeared to be simply additive. Collectively, our data indicated that JB6 cells expressed a functional FP coupled with transformation-related signal transduction and the regulation of clonal selection processes. Erk activity appears to be a convergence point in the EGF and FP pathways. The data raise the possibility that the FP contributes to clonal selection processes but probably plays a more important role as a response modifier.

Original languageEnglish (US)
Pages (from-to)163-172
Number of pages10
JournalMolecular Carcinogenesis
Volume35
Issue number4
DOIs
StatePublished - Dec 1 2002

Fingerprint

Dinoprost
Extracellular Signal-Regulated MAP Kinases
Epidermal Growth Factor
Signal Transduction
prostaglandin F2alpha receptor
Phosphatidylinositols
Reverse Transcription
Carcinogenesis
Polymerase Chain Reaction
Messenger RNA
Skin

Keywords

  • Convergence
  • Cyclooxygenase
  • Epidermal
  • Extracellular signal-regulated kinase

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F receptor. / Weber, Thomas J.; Markillie, Lye M.; Chrisler, William B.; Vielhauer, George A.; Regan, John W.

In: Molecular Carcinogenesis, Vol. 35, No. 4, 01.12.2002, p. 163-172.

Research output: Contribution to journalArticle

Weber, Thomas J. ; Markillie, Lye M. ; Chrisler, William B. ; Vielhauer, George A. ; Regan, John W. / Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F receptor. In: Molecular Carcinogenesis. 2002 ; Vol. 35, No. 4. pp. 163-172.
@article{cbe9bd0dd37e430988015d490a8a8751,
title = "Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F2α receptor",
abstract = "Prostaglandin F2α (PGF2α) modulates clonal selection processes in the mouse skin model of carcinogenesis. In this study we investigated whether JB6 mouse epidermal cells expressed a functional PGF2α receptor (FP) coupled with a cell-transformation response. Treatment of JB6 cells with an FP agonist (fluprostenol) potently (pM-nM) increased anchorage-dependent and anchorage-independent growth. Inositol phospholipid accumulation and extracellular signal-regulated kinase (Erk) activity were increased in cells treated with FP agonists, consistent with established FP- related signal transduction. FP mRNA was detected by reverse transcription-polymerase chain reaction, and the average specific [3H]PGF2α binding was 8.25 ± 0.95 fmol/mg protein. Erk activity and colony size were increased by cotreatment of JB6 cells with epidermal growth factor (EGF) and fluprostenol to a greater extent than with either treatment alone, whereas the cotreatment effect on colony number appeared to be simply additive. Collectively, our data indicated that JB6 cells expressed a functional FP coupled with transformation-related signal transduction and the regulation of clonal selection processes. Erk activity appears to be a convergence point in the EGF and FP pathways. The data raise the possibility that the FP contributes to clonal selection processes but probably plays a more important role as a response modifier.",
keywords = "Convergence, Cyclooxygenase, Epidermal, Extracellular signal-regulated kinase",
author = "Weber, {Thomas J.} and Markillie, {Lye M.} and Chrisler, {William B.} and Vielhauer, {George A.} and Regan, {John W}",
year = "2002",
month = "12",
day = "1",
doi = "10.1002/mc.10079",
language = "English (US)",
volume = "35",
pages = "163--172",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F2α receptor

AU - Weber, Thomas J.

AU - Markillie, Lye M.

AU - Chrisler, William B.

AU - Vielhauer, George A.

AU - Regan, John W

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Prostaglandin F2α (PGF2α) modulates clonal selection processes in the mouse skin model of carcinogenesis. In this study we investigated whether JB6 mouse epidermal cells expressed a functional PGF2α receptor (FP) coupled with a cell-transformation response. Treatment of JB6 cells with an FP agonist (fluprostenol) potently (pM-nM) increased anchorage-dependent and anchorage-independent growth. Inositol phospholipid accumulation and extracellular signal-regulated kinase (Erk) activity were increased in cells treated with FP agonists, consistent with established FP- related signal transduction. FP mRNA was detected by reverse transcription-polymerase chain reaction, and the average specific [3H]PGF2α binding was 8.25 ± 0.95 fmol/mg protein. Erk activity and colony size were increased by cotreatment of JB6 cells with epidermal growth factor (EGF) and fluprostenol to a greater extent than with either treatment alone, whereas the cotreatment effect on colony number appeared to be simply additive. Collectively, our data indicated that JB6 cells expressed a functional FP coupled with transformation-related signal transduction and the regulation of clonal selection processes. Erk activity appears to be a convergence point in the EGF and FP pathways. The data raise the possibility that the FP contributes to clonal selection processes but probably plays a more important role as a response modifier.

AB - Prostaglandin F2α (PGF2α) modulates clonal selection processes in the mouse skin model of carcinogenesis. In this study we investigated whether JB6 mouse epidermal cells expressed a functional PGF2α receptor (FP) coupled with a cell-transformation response. Treatment of JB6 cells with an FP agonist (fluprostenol) potently (pM-nM) increased anchorage-dependent and anchorage-independent growth. Inositol phospholipid accumulation and extracellular signal-regulated kinase (Erk) activity were increased in cells treated with FP agonists, consistent with established FP- related signal transduction. FP mRNA was detected by reverse transcription-polymerase chain reaction, and the average specific [3H]PGF2α binding was 8.25 ± 0.95 fmol/mg protein. Erk activity and colony size were increased by cotreatment of JB6 cells with epidermal growth factor (EGF) and fluprostenol to a greater extent than with either treatment alone, whereas the cotreatment effect on colony number appeared to be simply additive. Collectively, our data indicated that JB6 cells expressed a functional FP coupled with transformation-related signal transduction and the regulation of clonal selection processes. Erk activity appears to be a convergence point in the EGF and FP pathways. The data raise the possibility that the FP contributes to clonal selection processes but probably plays a more important role as a response modifier.

KW - Convergence

KW - Cyclooxygenase

KW - Epidermal

KW - Extracellular signal-regulated kinase

UR - http://www.scopus.com/inward/record.url?scp=0036924685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036924685&partnerID=8YFLogxK

U2 - 10.1002/mc.10079

DO - 10.1002/mc.10079

M3 - Article

VL - 35

SP - 163

EP - 172

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 4

ER -